ACT DMD Update with PTC (February 2014) On February 5, 2014, Dr. Robert Spiegel, Chief Medical Officer at PTC Therapeutics, presented an update about PTC’s Phase 3 study of ataluren, now known as the Ataluren Confirmatory Trial in DMD (ACT DMD). Research & Clinical Trial Webinars,Webinars 11 years ago You may also like 1:00:20 Orthopedic Complications in Duchenne (March 2015) 10 years ago Care Webinars,Webinars 1:00:48 Dystrophin 101 Webinar (March 2015) 10 years ago Research & Clinical Trial Webinars,Webinars 1:01:10 Combination Therapies Webinar (December 2014) 10 years ago Research & Clinical Trial Webinars,Webinars 1:01:31 Duchenne Pulmonary Care for Adults Webinar (November 2014) 10 years ago Care Webinars,Webinars 55:34 Middle Pulmonary Care Webinar (October 2014) 10 years ago Care Webinars,Webinars 47:50 Efficacy of Catena®/Raxone® (Idebenone) on Respiratory Outcome in Duchenne (October 2014) 10 years ago Research & Clinical Trial Webinars,Webinars 1:07:03 Prosensa Update about Drisapersen & Other Programs (October 2014) 10 years ago Research & Clinical Trial Webinars,Webinars 1:05:45 Early Pulmonary Care Webinar (September 2014) 10 years ago Care Webinars,Webinars «1…202122232425»Page 22 of 25
by: Parent Project Muscular Dystrophy
